Ernest Moles
Sydney, NSW 2052, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Comparative analysis of clinically approved lipid nanoparticles for intranasal siRNA delivery against SARS-CoV-2.
Journal: Drug delivery and translational research
Published: December 02, 2025
Harnessing antiviral RNAi therapeutics for pandemic viruses: SARS-CoV-2 and HIV.
Journal: Drug delivery and translational research
Published: December 24, 2024
EGFR Targeting of Liposomal Doxorubicin Improves Recognition and Suppression of Non-Small Cell Lung Cancer.
Journal: International journal of nanomedicine
Published: November 18, 2023
Targeted delivery of polo-like kinase 1 siRNA nanoparticles using an EGFR-PEG bispecific antibody inhibits proliferation of high-risk neuroblastoma.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: June 28, 2023
Delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment in models of high-risk childhood leukemia.
Journal: Science translational medicine
Published: May 17, 2023
An antibody fragment-decorated liposomal conjugate targets Philadelphia-like acute lymphoblastic leukemia.
Journal: International journal of biological macromolecules
Published: February 15, 2023
Systematic In Vitro Evaluation of a Library of Approved and Pharmacologically Active Compounds for the Identification of Novel Candidate Drugs for KMT2A-Rearranged Leukemia.
Journal: Frontiers in oncology
Published: September 20, 2021
Development of siRNA-Loaded Lipid Nanoparticles Targeting Long Non-Coding RNA LINC01257 as a Novel and Safe Therapeutic Approach for t(8;21) Pediatric Acute Myeloid Leukemia.
Journal: Pharmaceutics
Published: August 17, 2021
Development of DNA Aptamers Against Plasmodium falciparum Blood Stages Using Cell-Systematic Evolution of Ligands by EXponential Enrichment.
Journal: Journal of biomedical nanotechnology
Published: June 05, 2020
An ImmunoPEGliposome for Targeted Antimalarial Combination Therapy at the Nanoscale.
Journal: Pharmaceutics
Published: June 03, 2019
Modeling the Distribution of Diprotic Basic Drugs in Liposomal Systems: Perspectives on Malaria Nanotherapy.
Journal: Frontiers in pharmacology
Published: March 08, 2019
Structure-activity relationship of new antimalarial 1-aryl-3-susbtituted propanol derivatives: Synthesis, preliminary toxicity profiling, parasite life cycle stage studies, target exploration, and targeted delivery.
Journal: European journal of medicinal chemistry
Published: February 18, 2018
Last Updated: 09/26/2026